Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cannabis Dependence: early-phase trial registry
2 of 13 indexed Cannabis Dependence trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,315 of 28,707 conditions by registered trial count.
13 US clinical trials · 2 currently recruiting · #1,315 of 28,707 conditions by registered trial count
Cannabis Dependence: 13 US clinical trials tracked, 2 recruiting.
Cannabis Dependence is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute on Drug Abuse (NIDA), running 2 of these trials.
Enrollment posture brief
Registry condition cannabis-dependence
OPEN 2 | RECR 15% | LATE 2 | EARLY 4 | RANK #1315 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Arthroplasty, Replacement, Knee (15% recruiting · 13 trials)
Cannabis Dependence lists 2 open slots (15% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cannabis Dependence on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cannabis Dependence is recruiting below its size-band peers.
2 of 13 indexed trials (15.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Cannabis Dependence research.
National Institute on Drug Abuse (NIDA) accounts for 2 of 13 trials (15.4%). 11 distinct sponsors appear on at least one study for this condition label.
-
Most Cannabis Dependence trials plan to enrol fewer than 100 people.
Median target enrolment is 70 among the 13 trials that report a genuine target (sentinel values excluded). 9 of those (69.2%) plan for fewer than 100 participants.
-
Cannabis Dependence research is mostly interventional.
10 interventional and 3 observational studies make up this index (76.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
13 total, page 1 of 1
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Yale University
NCT01730781
Neuroimaging of Adolescent Cannabis Use Treatment
Indiana University
NCT07340554
Breathwork-assisted Treatment for Cannabis Use Disorder
Elias Dakwar
NCT05219825
Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms
National Institute on Drug Abuse (NIDA)
NCT01603992
Improving Substance Use and Clinical Outcomes in Heavy Cannabis Users With Quetiapine
Northwell Health
NCT01153490
Risk Perception in Drug-Dependent Adults With and Without Schizophrenia
National Institute on Drug Abuse (NIDA)
NCT01031563
Treatment for Cannabis Withdrawal and Dependence
The Scripps Research Institute
NCT01611948
Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal
Yale University
NCT01618656
Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders
Louisiana State University and A&M College
NCT01875796
Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting
Hunter Holmes Mcguire Veteran Affairs Medical Center
NCT03662529
Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders
Dartmouth-Hitchcock Medical Center
NCT01834794
An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents
Medical University of South Carolina
NCT00542750
Reducing Cannabis Overuse With Prazosin
VA Puget Sound Health Care System
NCT04721353
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Cannabis Dependence records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cannabis Dependence trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cannabis Dependence page
13 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Cannabis Dependence trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute on Drug Abuse (NIDA) sponsors the most Cannabis Dependence trials on record, review their full trial history before evaluating a specific study. See National Institute on Drug Abuse (NIDA)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cannabis Dependence condition card totals 13 registered trials; most-linked intervention Placebo; top US site state South Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.